nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.06.2014 | Image of the Month

FDG PET/CT in autoimmune pancreatitis

verfasst von: Cristina Nanni, Rossella Romagnoli, Ilaria Rambaldi, Paola Caroli, Federica Matteucci, Valentina Ambrosini, Giuseppe Re, Stefano Fanti

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Excerpt

A 72-year-old male patient was admitted to the Emergency Room with acute jaundice in the absence of other clinical symptoms. Laboratory data demonstrated direct hyperbilirubinaemia related to an obstruction in the biliary tree. Endoscopic retrograde cholangiopancreatography was planned and a stent was placed in the common bile duct (e, yellow arrow) with progressive resolution of the jaundice. A biopsy of the ampulla of Vater was performed and was negative for cancer. Abdominal CT and MRI scans were performed to exclude pancreatic cancer and were negative. …

Ketwaroo GA, Sheth S. Autoimmune pancreatitis. Gastroenterol Rep. 2013;1(1):27–32.PubMedCrossRef

Dong A, Dong H, Zhang L, Zuo C. Hypermetabolic lesions of the pancreas on FDG PET/CT. Clin Nucl Med. 2013;38(9):e354–66.PubMedCrossRef

Titel: FDG PET/CT in autoimmune pancreatitis
verfasst von: Cristina Nanni
Rossella Romagnoli
Ilaria Rambaldi
Paola Caroli
Federica Matteucci
Valentina Ambrosini
Giuseppe Re
Stefano Fanti
Publikationsdatum: 01.06.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2014
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-014-2699-5

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2014

Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients

PET/MR attenuation correction: where have we come from and where are we going?

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues

Ignasi Carrio and Pablo Ros (Eds.): PET/MRI Methodology and Clinical Applications

Response to comment by Aprile et al.: The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer